TrialBlood advances2020

Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.

Andrés J M Ferreri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.